Structures by: Jones W.
Total: 266
C12H8N2,C5H6O4,H2O
C12H8N2,C5H6O4,H2O
CrystEngComm (2013) 15, 1 175
a=27.495(2)Å b=14.043(2)Å c=4.0898(4)Å
α=90.00° β=90.00° γ=90.00°
Nicotinamide:pimelic acid 1:1
C7H12O4,C6H6N2O
CrystEngComm (2009) 11, 3 470
a=5.4425(1)Å b=7.3981(2)Å c=17.9304(6)Å
α=99.568(2)° β=94.075(2)° γ=104.177(2)°
Nicotinamide:suberic acid 1:1
C6H6N2O,C8H14O4
CrystEngComm (2009) 11, 3 470
a=4.95370(10)Å b=35.2893(6)Å c=8.7180(2)Å
α=90.00° β=94.8320(10)° γ=90.00°
C7H5NO4,C5H9NO
C7H5NO4,C5H9NO
CrystEngComm (2012) 14, 7 2552
a=6.6109(1)Å b=6.9719(2)Å c=13.9678(3)Å
α=93.855(1)° β=97.257(1)° γ=101.429(1)°
Pyrimethamine+carbamazepine+methanol
C15H12N2O,C12H13ClN4,2(CH4O)
CrystEngComm (2013) 15, 15 2916
a=7.96900(10)Å b=10.11220(10)Å c=17.9406(3)Å
α=92.9360(10)° β=94.1630(10)° γ=106.0620(10)°
Lawsone-bipyridyl
2(C10H6O3),C10H8N2
CrystEngComm (2015) 17, 40 7684
a=10.6360(3)Å b=4.7798(1)Å c=23.0987(9)Å
α=90.00° β=96.131(2)° γ=90.00°
Lawsone-ethylenebipyridine
C12H12N22,2(C10H5O31)
CrystEngComm (2015) 17, 40 7684
a=3.8157(1)Å b=28.0772(7)Å c=11.2326(3)Å
α=90.00° β=96.542(2)° γ=90.00°
Lawsone-hydroxypyridine
C15H11NO4
CrystEngComm (2015) 17, 40 7684
a=13.6937(12)Å b=5.1534(3)Å c=17.5288(12)Å
α=90° β=92.329(7)° γ=90°
Zn(MTT)2
C8H8N2O2S4Zn
Journal of the Chemical Society, Dalton Transactions (2001) 20 3045
a=7.6216(4)Å b=7.6954(4)Å c=11.7788(6)Å
α=105.147(3)° β=96.210(3)° γ=106.593(3)°
Ni(MTT)2
Ni3,6(C4H4N1O1S2)
Journal of the Chemical Society, Dalton Transactions (2001) 20 3045
a=10.067(5)Å b=10.167(8)Å c=11.184(4)Å
α=92.71(6)° β=114.00(4)° γ=112.92(5)°
Cu(MTT)2
(C4H4NOS2)2Cu
Journal of the Chemical Society, Dalton Transactions (2001) 20 3045
a=4.0859(2)Å b=12.7571(8)Å c=11.9876(7)Å
α=90.0° β=97.010(7)° γ=90.0°
C8H10N4O2,C5H8O4
C8H10N4O2,C5H8O4
Chemical communications (Cambridge, England) (2004) 7 890-891
a=13.0129(5)Å b=6.6017(2)Å c=17.1427(8)Å
α=90.00° β=97.8360(10)° γ=90.00°
C8H10N4O2,C5H8O4
C8H10N4O2,C5H8O4
Chemical communications (Cambridge, England) (2004) 7 890-891
a=8.3212(8)Å b=8.6667(8)Å c=11.3636(12)Å
α=68.955(4)° β=78.559(4)° γ=74.236(4)°
7105349
Chemical communications (Cambridge, England) (2010) 46, 13 2224-2226
a=5.0907Å b=12.9686Å c=9.2368Å
α=94.0829° β=112.577° γ=104.714°
Theobromine acetic acid
C7H8N4O2,C2H4O2
Chemical communications (Cambridge, England) (2010) 46, 13 2224-2226
a=5.2185(4)Å b=8.2901(8)Å c=12.9358(11)Å
α=95.827(6)° β=96.854(6)° γ=100.333(8)°
Caffeine:Theophylline cocrystal
C8H10N4O2,C7H8N4O2
Chem.Commun. (2012) 48, 8075
a=7.0081(7)Å b=8.7904(7)Å c=13.0856(15)Å
α=95.648(8)° β=97.090(9)° γ=91.667(8)°
Caffeine-D-tartaric acid 1/1
C8H10N4O2,C4H6O6
Chemical Communications (2006) 48
a=5.8024(1)Å b=10.0260(1)Å c=25.3674(4)Å
α=90.00° β=90.00° γ=90.00°
Theophylline L-tartaric acid 2/1
C4H6O6,2(C7H8N4O2)
Chemical Communications (2006) 48
a=8.9522(4)Å b=6.7582(5)Å c=18.8755(14)Å
α=90.0° β=100.685(4)° γ=90.0°
Theophylline DL-tartaric acid 2/1
C4H6O6,2(C7H8N4O2)
Chemical Communications (2006) 48
a=7.3102(1)Å b=8.3730(1)Å c=17.9724(3)Å
α=98.294(1)° β=99.466(1)° γ=94.527(1)°
Maleic Acid
C4H4O4
Chemical Communications (2006)
a=7.4749(8)Å b=10.0849(12)Å c=7.5465(7)Å
α=90.00° β=124.423(6)° γ=90.00°
Maleic Acid
C4H4O4
Chemical Communications (2006)
a=3.6933(3)Å b=7.4840(5)Å c=8.5933(7)Å
α=90.00° β=102.220(3)° γ=90.00°
Trimethoprim succinate
C14H19N4O3,0.5(C4H4O4)
Chemical Communications (2006)
a=17.343(4)Å b=11.672(2)Å c=16.835(3)Å
α=90.00° β=91.95(3)° γ=90.00°
Theophylline - DL-malic acid 1/1
C11H14N4O7
Chemical communications (Cambridge, England) (2008) 14 1644-1646
a=14.9572(8)Å b=6.07159(26)Å c=15.5163(6)Å
α=90.0° β=106.4298(17)° γ=90.0°
Theophylline - D-malic acid 1/1
C11H14N4O7
Chemical communications (Cambridge, England) (2008) 14 1644-1646
a=15.8592(8)Å b=6.07909(30)Å c=14.6549(9)Å
α=90.0° β=108.5890(19)° γ=90.0°
2,3 lutidine pamoate
2(C7H10N),C23H14O6
CrystEngComm (2009) 11, 2 254-260
a=15.197(3)Å b=13.262(3)Å c=15.716(3)Å
α=90.00° β=107.20(3)° γ=90.00°
3,4 lutidine pamoate
C23H14O6,2(C7H10N)
CrystEngComm (2009) 11, 2 254-260
a=11.196(2)Å b=12.653(3)Å c=22.963(5)Å
α=104.32(3)° β=103.24(3)° γ=91.58(3)°
2,4 lutidine pamoate
C23H14O6,2(C7H10N)
CrystEngComm (2009) 11, 2 254-260
a=8.2989(17)Å b=11.453(2)Å c=16.924(3)Å
α=72.76(3)° β=85.65(3)° γ=77.85(3)°
Artemisinin-resorcinol 2/1
2(C15H22O5),C6H6O2
CrystEngComm (2010) 12, 12 4038
a=9.5298(2)Å b=17.3699(4)Å c=10.4197(3)Å
α=90.00° β=94.0170(10)° γ=90.00°
Artemisinin-orcinol 1/1
C15H22O5,C7H8O2
CrystEngComm (2010) 12, 12 4038
a=9.0658(1)Å b=14.1061(3)Å c=16.5554(3)Å
α=90.00° β=90.00° γ=90.00°
C13H9BrN1,Br1,H2O
C13H9BrN1,Br1,H2O
CrystEngComm (2014) 16, 47 10830
a=7.3152(6)Å b=9.7141(9)Å c=10.352(2)Å
α=68.687(3)° β=86.209(3)° γ=68.298(4)°
C13H9IN1,I31
C13H9IN1,I31
CrystEngComm (2014) 16, 47 10830
a=7.5081(3)Å b=10.4940(5)Å c=11.7322(6)Å
α=105.219(2)° β=105.581(2)° γ=101.791(2)°
C14H12N1,Br1,H2O
C14H12N1,Br1,H2O
CrystEngComm (2014) 16, 47 10830
a=7.7990(10)Å b=9.585(2)Å c=9.664(2)Å
α=68.967(7)° β=70.925(6)° γ=83.339(6)°
C34H36N22,2(Br1),H2O
C34H36N22,2(Br1),H2O
CrystEngComm (2014) 16, 47 10830
a=7.7034(7)Å b=9.1410(10)Å c=12.257(2)Å
α=88.730(6)° β=78.321(6)° γ=71.486(4)°
C13H9IN1,Br1,H2O
C13H9IN1,Br1,H2O
CrystEngComm (2014) 16, 47 10830
a=7.5841(6)Å b=19.2894(16)Å c=9.3211(9)Å
α=90° β=105.886(4)° γ=90°
Fluorescein:phenantridine cocrystal
(C20H12O5),(C13H9N1)2
CrystEngComm (2013) 15, 32 6289
a=27.7697(34)Å b=15.4238(20)Å c=7.98164(85)Å
α=90° β=90° γ=90°
Fluorescein:pyrazine cocrystal
(C20H12O5),(C4H4N2)
CrystEngComm (2013) 15, 32 6289
a=7.81238(87)Å b=19.0241(17)Å c=12.7880(14)Å
α=90° β=91.1378(67)° γ=90°
C20H12O5,2(C13H9N)
C20H12O5,2(C13H9N)
CrystEngComm (2013) 15, 32 6289
a=27.6912(12)Å b=15.3574(9)Å c=7.8814(4)Å
α=90° β=90° γ=90°
C20H12O5,2(C13H9N)
C20H12O5,2(C13H9N)
CrystEngComm (2013) 15, 32 6289
a=8.6428(3)Å b=19.6270(7)Å c=20.9268(9)Å
α=90° β=98.748(4)° γ=90°
C40H24O10,C4H4N2,2(CH4O)
C40H24O10,C4H4N2,2(CH4O)
CrystEngComm (2013) 15, 32 6289
a=7.6060(4)Å b=11.1161(9)Å c=12.0927(8)Å
α=115.965(7)° β=93.139(5)° γ=92.811(6)°
C13H9FN1,Br1,H2O
C13H9FN1,Br1,H2O
CrystEngComm (2014) 16, 47 10830
a=10.4896(4)Å b=12.9381(5)Å c=9.9423(3)Å
α=90° β=117.876(3)° γ=90°
C13H9ClN1,Br1,0.75(H2O)
C13H9ClN1,Br1,0.75(H2O)
CrystEngComm (2014) 16, 47 10830
a=9.5818(3)Å b=11.4519(3)Å c=12.5667(4)Å
α=109.027(2)° β=94.230(2)° γ=105.253(2)°
Caffeine:anthranilic acid co-crystal
C8H10N4O2,C7H7NO2
Acta Crystallographica Section B (2014) 70, 1 72-80
a=14.53798(14)Å b=11.07930(8)Å c=10.02456(7)Å
α=90° β=90° γ=90°
Caffeine:anthranilic acid co-crystal
C8H10N4O2,C7H7NO2
Acta Crystallographica Section B (2014) 70, 1 72-80
a=8.4853(2)Å b=13.4240(3)Å c=14.8856(4)Å
α=111.7249(16)° β=92.8464(15)° γ=93.5278(9)°
Caffeine:anthranilic acid hemichlorobenzene
2(C8H10N4O2),2(C7H7NO2),C6H5Cl
Acta Crystallographica Section B (2014) 70, 1 72-80
a=12.4390(2)Å b=13.1409(2)Å c=13.2251(3)Å
α=69.439(1)° β=80.418(1)° γ=63.557(1)°
Caffeine:anthranilic acid hemitoluene
2(C8H10N4O2),2(C7H7NO2),C7H8
Acta Crystallographica Section B (2014) 70, 1 72-80
a=12.475(9)Å b=13.488(9)Å c=13.316(9)Å
α=68.318(11)° β=79.948(16)° γ=64.124(11)°
Caffeine:anthranilic acid hemibromobenzene
2(C8H10N4O2),2(C7H7NO2),C6H5Br
Acta Crystallographica Section B (2014) 70, 1 72-80
a=12.569(3)Å b=13.409(3)Å c=13.269(3)Å
α=68.991(4)° β=80.215(5)° γ=64.007(4)°
Caffeine:anthranilic acid mono o-xylene
C8H10N4O2,C7H7NO2,C8H10
Acta Crystallographica Section B (2014) 70, 1 72-80
a=13.8492(3)Å b=6.7890(2)Å c=23.3960(7)Å
α=90.00° β=92.260(1)° γ=90.00°
Caffeine:anthranilic acid mono toluene
C8H10N4O2,C7H7NO2,C7H8
Acta Crystallographica Section B (2014) 70, 1 72-80
a=6.7113(3)Å b=13.5803(6)Å c=23.579(2)Å
α=87.100(2)° β=88.572(2)° γ=86.065(2)°
Theobromine:anthranilic acid co-crystal
C7H8N4O2,C7H7NO2
Acta Crystallographica Section B (2014) 70, 1 72-80
a=6.5769(10)Å b=21.905(3)Å c=11.0496(16)Å
α=90° β=112.912(6)° γ=90°
Caffeine:anthranilic acid sesqui p-xylene
C8H10N4O2,C7H7NO2,1.5(C8H10)
Acta Crystallographica Section B (2014) 70, 1 72-80
a=6.8474(8)Å b=13.431(2)Å c=14.440(3)Å
α=77.009(3)° β=86.596(4)° γ=88.687(8)°
Caffeine:anthranilic acid monohydrate
C8H10N4O2,C7H7NO2,H2O
Acta Crystallographica Section B (2014) 70, 1 72-80
a=10.2641(2)Å b=26.9469(7)Å c=11.9845(3)Å
α=90.00° β=103.547(2)° γ=90.00°
C14H19N21,C4H1Cl2O41
C14H19N21,C4H1Cl2O41
Acta Crystallographica Section B (1996) 52, 4 691-696
a=18.0860(10)Å b=6.9830(10)Å c=14.3630(10)Å
α=90.0° β=90.0° γ=90.0°
C11H13NO3
C11H13NO3
Acta Crystallographica Section B (1993) 49, 3 541-546
a=5.120(6)Å b=6.595(2)Å c=15.786(3)Å
α=100.98(2)° β=94.48(5)° γ=98.15(5)°
C12H15NO3
C12H15NO3
Acta Crystallographica Section B (1993) 49, 3 541-546
a=5.081(4)Å b=24.066(6)Å c=9.662(4)Å
α=90° β=82.06(6)° γ=90°
C11H13NO4
C11H13NO4
Acta Crystallographica Section B (1993) 49, 3 541-546
a=5.1350(10)Å b=24.556(5)Å c=9.496(2)Å
α=90° β=105.33(3)° γ=90°
C16H23NO3
C16H23NO3
Acta Crystallographica Section B (1993) 49, 3 541-546
a=5.1760(10)Å b=6.731(5)Å c=22.127(17)Å
α=92.79(6)° β=91.13(4)° γ=100.04(4)°
Allo-inositol
C6H12O6
Acta Crystallographica Section E (2006) 62, 7 o2578-o2579
a=4.9520(2)Å b=11.3145(6)Å c=12.7326(6)Å
α=90.00° β=91.142(3)° γ=90.00°
Quinolinium Fumarate
C9H8N1,C4H3O41
Acta Crystallographica Section E (2003) 59, 4 o397-o398
a=22.5838(5)Å b=3.72730(10)Å c=13.2912(5)Å
α=90.00° β=90.00° γ=90.00°
2-(p-Nitrophenoxy)terahydropyran
C11H13NO4
Acta Crystallographica Section E (2004) 60, 11 o1923-o1924
a=7.47720(10)Å b=21.9462(4)Å c=6.78280(10)Å
α=90.00° β=102.4910(10)° γ=90.00°
Indomethacin methyl ester
C20H18ClNO4
Acta Crystallographica Section E (2004) 60, 4 o508-o509
a=19.0206(5)Å b=4.83260(10)Å c=19.3092(8)Å
α=90.00° β=97.7390(10)° γ=90.00°
Pamoic Acid
C23H16O6
Acta Crystallographica Section E (2006) 62, 3 o1170-o1172
a=19.7348(7)Å b=4.78768(12)Å c=19.2544(4)Å
α=90° β=108.9622(17)° γ=90°
Myo-inositol
C6H12O6,2H2O
Acta Crystallographica Section E (2006) 62, 7 o2902-o2904
a=6.6099(2)Å b=16.6009(4)Å c=9.0264(2)Å
α=90.00° β=110.7510(10)° γ=90.00°
NTA--1,10-phenanthroline--water (1/1/1)
C6H8NO6,C12H9N2,H2O
Acta Crystallographica Section E (2001) 57, 8 o811-o813
a=22.7045(6)Å b=11.1044(3)Å c=14.2366(2)Å
α=90.00° β=90.00° γ=90.00°
P-Xylene-α,α-diol
C8H10O2
Acta Crystallographica Section E (2001) 57, 12 o1233-o1234
a=4.8118(3)Å b=15.4697(14)Å c=9.7712(8)Å
α=90.00° β=101.798(5)° γ=90.00°
Acridine--isophthalic acid
C13H10N11,C8H5O41
Acta Crystallographica Section E (2001) 57, 10 o945-o946
a=8.5196(9)Å b=9.1440(10)Å c=11.386(4)Å
α=69.41(2)° β=89.440(10)° γ=84.220(10)°
Diphenic acid--acridine(1/1)
C14H10O4,C14H9O41,C13H9N,C13H10N1
Acta Crystallographica Section E (2001) 57, 11 o1075-o1077
a=14.461(3)Å b=15.863(3)Å c=19.166(3)Å
α=90.00° β=108.98(2)° γ=90.00°
Co(MTT)2(MeOH)2
C10H16CoN2O4S4
Acta Crystallographica Section E (2001) 57, 4 m140-m142
a=5.0414(4)Å b=18.878(2)Å c=8.6814(11)Å
α=90.00° β=99.349(7)° γ=90.00°
4,7-phenanthroline
C12H8N2
Acta Crystallographica Section E (2001) 57, 2 o145-o146
a=19.141(4)Å b=3.8417(4)Å c=11.564(2)Å
α=90.00° β=90.00° γ=90.00°
Sebacic acid
C10H18O4
Acta Crystallographica Section E (2001) 57, 2 o141-o142
a=10.9197(7)Å b=4.9876(6)Å c=9.9640(10)Å
α=90.00° β=92.273(6)° γ=90.00°
Azelaic acid
C9H16O4
Acta Crystallographica Section E (2001) 57, 2 o143-o144
a=22.622(2)Å b=4.7348(2)Å c=9.6864(7)Å
α=90.00° β=110.559(3)° γ=90.00°
3,5-dinitrobenzoic acid DMSO solvate
C7H4N2O6,C2H6OS
Acta Crystallographica Section E (2005) 61, 3 o609-o611
a=10.0156(2)Å b=12.0767(2)Å c=20.6483(5)Å
α=90.00° β=90.00° γ=90.00°
3,5-dinitro-4-methylbenzoic acid DMSO solvate
C8H6N2O6,C2H6OS
Acta Crystallographica Section E (2005) 61, 4 o1100-o1102
a=6.9483(2)Å b=22.4844(5)Å c=8.2364(2)Å
α=90.00° β=92.7650(10)° γ=90.00°
Citraconic acid
C5H6O4
Acta Crystallographica Section C (1998) 54, 2 238-240
a=5.4239(5)Å b=7.1863(9)Å c=8.1732(8)Å
α=88.860(9)° β=71.254(8)° γ=81.261(9)°
C13H9NO
C13H9NO
Acta Crystallographica, Section C: Crystal Structure Communications (1995) 51, 2 267-268
a=4.5330(10)Å b=16.537(3)Å c=12.687(3)Å
α=90.00° β=97.22(3)° γ=90.00°
Tetra-aqua-magnesium bis(o-hydroxy-trans-cinnamate)
C18H22MgO10
Acta Crystallographica Section C (1995) 51, 6 1051-1053
a=6.025(3)Å b=5.385(3)Å c=29.991(14)Å
α=90.00° β=94.46(4)° γ=90.00°
Bis(berberine) sulphate heptadydrate
2(C20H18NO41),O4S2,7H2O
Acta Crystallographica Section C (1995) 51, 6 1234-1240
a=23.198(30)Å b=6.918(10)Å c=24.963(30)Å
α=90.00° β=96.65(9)° γ=90.00°
Berberine Iodide
C20H18NO41,I1
Acta Crystallographica Section C (1995) 51, 6 1234-1240
a=7.0814(10)Å b=15.917(2)Å c=16.154(2)Å
α=90.00° β=99.126(10)° γ=90.00°
Berberine chloride ethanol solvate hemihydrate
C20H18NO41,Cl1,C2H6O,0.5H2O
Acta Crystallographica Section C (1995) 51, 6 1234-1240
a=7.3712(10)Å b=11.2724(10)Å c=13.3998(10)Å
α=77.587(7)° β=73.299(7)° γ=78.228(8)°
Berberine Chloride tetrahydrate
C20H18NO41,Cl1,4H2O
Acta Crystallographica Section C (1995) 51, 6 1234-1240
a=7.029(2)Å b=11.598(3)Å c=13.172(20)Å
α=103.85(2)° β=89.14(2)° γ=95.87°
Berberine bromide dihydrate
C20H18NO41,Br1,2H2O
Acta Crystallographica Section C (1995) 51, 6 1234-1240
a=21.974(3)Å b=7.200(7)Å c=26.151(3)Å
α=90.00° β=110.180(10)° γ=90.00°
Sodium o-chloro-trans-cinnamate dihydrate
C9H10Cl1Na1O4
Acta Crystallographica Section C (1995) 51, 6 1051-1053
a=14.506(4)Å b=3.7329(10)Å c=19.245(3)Å
α=90.00° β=91.45(2)° γ=90.00°
K1,C8H5O41,0.5H2O2
K1,C8H5O41,0.5H2O2
Acta Crystallographica Section C (1995) 51, 6 1128-1130
a=9.4770(10)Å b=7.4630(10)Å c=26.727(3)Å
α=90.00° β=90.00° γ=90.00°
P-propanamidoperbenzoic
C10H11NO4
Acta Crystallographica Section C (1996) 52, 4 919-923
a=4.8853(10)Å b=15.680(4)Å c=12.793(3)Å
α=90.00° β=92.21(2)° γ=90.00°
C11H9NO4
C11H9NO4
Acta Crystallographica Section C (1996) 52, 4 913-919
a=7.079(4)Å b=8.949(5)Å c=15.893(7)Å
α=90° β=98.84(4)° γ=90°
C10H7NO4
C10H7NO4
Acta Crystallographica Section C (1996) 52, 4 913-919
a=7.573(2)Å b=21.152(5)Å c=11.756(2)Å
α=90° β=90° γ=90°
C13H13NO4
C13H13NO4
Acta Crystallographica Section C (1996) 52, 4 913-919
a=6.574(4)Å b=4.899(2)Å c=37.413(13)Å
α=90° β=95.18(3)° γ=90°
C12H11NO4
C12H11NO4
Acta Crystallographica Section C (1996) 52, 4 913-919
a=7.336(6)Å b=10.950(3)Å c=14.693(5)Å
α=100.79(3)° β=104.50(5)° γ=83.53(6)°
C14H15NO4
C14H15NO4
Acta Crystallographica Section C (1996) 52, 4 913-919
a=21.055(8)Å b=4.662(1)Å c=28.067(9)Å
α=90° β=105.22(3)° γ=90°
C9H9N1O4
C9H9N1O4
Acta Crystallographica Section C (1996) 52, 4 919-923
a=5.0540(10)Å b=14.747(5)Å c=12.568(3)Å
α=90° β=92.88(2)° γ=90°
C11H13N1O4
C11H13N1O4
Acta Crystallographica Section C (1996) 52, 4 919-923
a=10.750(3)Å b=14.477(6)Å c=6.875(3)Å
α=90° β=90° γ=90°
C12H15N1O4
C12H15N1O4
Acta Crystallographica Section C (1996) 52, 4 919-923
a=10.729(5)Å b=14.026(7)Å c=8.654(3)Å
α=90° β=111.59(3)° γ=90°
C12H8N2
C12H8N2
Acta Crystallographica Section C (1991) 47, 5 1113-1114
a=7.0830(10)Å b=5.0720(10)Å c=12.794(8)Å
α=90° β=102.34(2)° γ=90°
C16H22CoO14
C16H22CoO14
Acta Crystallographica Section C (1993) 49, 12 2100-2102
a=12.760(6)Å b=5.319(4)Å c=14.933(8)Å
α=90.0° β=91.05(4)° γ=90.0°
Potassium 4-Sulfonatobenzoic acid dihydrate
C7H9KO7S
Acta Crystallographica Section C (1995) 51, 5 867-871
a=8.6449(10)Å b=9.9416(10)Å c=12.892(2)Å
α=90.00° β=94.96(9)° γ=90.00°
Potassium 4-sulfonatobenzoic acid
C7H5KO5S
Acta Crystallographica Section C (1995) 51, 5 867-871
a=6.3113(10)Å b=7.5404(10)Å c=9.8868(10)Å
α=103.832(10)° β=99.202(10)° γ=100.707(10)°
Potassium 4-sulfonatobenzoic acid monohydrate
C7H7KO6S
Acta Crystallographica Section C (1995) 51, 5 867-871
a=6.0576(10)Å b=6.7412(10)Å c=12.479(2)Å
α=90.278(10)° β=95.841(10)° γ=106.379(10)°
C10H11NO3
C10H11NO3
Acta Crystallographica Section C (1994) 50, 5 813-816
a=15.9300(10)Å b=10.860(2)Å c=11.135(4)Å
α=90.0° β=90.0° γ=90.0°
2-saccharinperethanoic acid monohydrate
C9H7NO6S,H2O
Acta Crystallographica Section C (1996) 52, 9 2323-2326
a=9.013(3)Å b=7.055(4)Å c=18.118(2)Å
α=90.° β=98.51(2)° γ=90.°
5-saccharinpentanoic acid monohydrate
C12H13NO5S,H2O
Acta Crystallographica Section C (1996) 52, 9 2323-2326
a=8.412(3)Å b=9.190(3)Å c=10.880(6)Å
α=66.74(3)° β=88.86(3)° γ=64.67(3)°
C12H15NO3
C12H15NO3
Acta Crystallographica Section C (1994) 50, 5 816-820
a=24.220(9)Å b=9.675(6)Å c=10.094(6)Å
α=90.° β=90.° γ=90.°